|
Merck Animal Health to Acquire Vence27 Sep 2022
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck &... Continue Reading
|
|
Sesen Bio and Carisma Therapeutics Announce Merger Agreement27 Sep 2022
Sesen Bio, Inc. (Nasdaq: SESN) and Carisma Therapeutics Inc. (Carisma), a privately held, clinical stage biopharmaceutical company focused on discovering... Continue Reading
|
|
Rocket Fuels AAV Cardiac Portfolio with Renovacor Buy27 Sep 2022
Shares of Renovacor, Inc. are surging in premarket trading following Rocket Pharmaceuticals’ announcement it will acquire the company in an... Continue Reading
|
|
Gilead Sciences Completes Acquisition of MiroBio27 Sep 2022
Gilead Sciences, Inc., (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire MiroBio, a privately held... Continue Reading
|
|
Veranex Expands European MedTech Capabilities with Acquisition of Medidee27 Sep 2022
Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has... Continue Reading
|
|
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-Based Cardiac Gene Therapy27 Sep 2022
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies... Continue Reading
|
|
Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to Its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy27 Sep 2022
Optimind Pharma Corp. (CSE: OMND) (“Optimind” or the “Company”) an emerging provider of psychedelic therapies focused on improving the everyday... Continue Reading
|
|
Amare Global Announces Acquisition of Kyäni, Inc.27 Sep 2022
Amare Global, The Mental Wellness Company, announced today the acquisition of Kyäni, Inc., a globally recognized and respected pioneer in... Continue Reading
|
|
GENFIT Drops up to $105M for Versantis to up Liver Game27 Sep 2022
GENFIT is acquiring liver-disease specialist Versantis for roughly $40 million cash and up to approximately $65 million in milestone payments... Continue Reading
|
|
H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 DaysWound Healing and Limb Salvaging Technology Adds to Company’s Asset Portfolio Focused on Unmet Medical Needs27 Sep 2022
“The acquisition of SkinDisc represents another significant addition to our portfolio of potentially life-saving technologies under development,” said Michael Yurkowsky,... Continue Reading
|